SG3 Management, LLC - IMMUNOGEN INC ownership

IMMUNOGEN INC's ticker is IMGN and the CUSIP is 45253H101. A total of 221 filers reported holding IMMUNOGEN INC in Q3 2021. The put-call ratio across all filers is 0.30 and the average weighting 0.1%.

Quarter-by-quarter ownership
SG3 Management, LLC ownership history of IMMUNOGEN INC
ValueSharesWeighting
Q1 2022$411,000
-7.6%
86,400
+10.1%
0.01%
-7.7%
Q3 2021$445,000
-55.1%
78,500
-47.8%
0.01%
-63.9%
Q2 2021$992,000
+22.5%
150,500
+50.5%
0.04%
+80.0%
Q1 2021$810,000
+25.6%
100,0000.0%0.02%
+66.7%
Q4 2020$645,000
+1797.1%
100,000
+900.0%
0.01%
+140.0%
Q1 2020$34,00010,0000.01%
Other shareholders
IMMUNOGEN INC shareholders Q3 2021
NameSharesValueWeighting ↓
Redmile Group, LLC 10,906,962$69,914,0003.04%
Fernwood Investment Management, LLC 224,500$1,439,0000.77%
Telemetry Investments, L.L.C. 272,000$1,744,0000.66%
Schonfeld Strategic Advisors LLC 865,356$5,547,0000.45%
Virtus ETF Advisers LLC 53,977$346,0000.43%
Endurant Capital Management LP 210,800$1,351,0000.41%
SPHERA FUNDS MANAGEMENT LTD. 500,000$3,205,0000.38%
TWIN FOCUS CAPITAL PARTNERS, LLC 113,216$726,0000.37%
Orbimed Advisors 2,834,126$18,167,0000.23%
PINNACLE ASSOCIATES LTD 1,322,231$8,476,0000.16%
View complete list of IMMUNOGEN INC shareholders